Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, C. Allison Stewart et al.|Cancer Cell|2021Cited by 930
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary CarcinomaPavlos Msaouel, Nizar M. Tannir, Cristian Coarfa et al.|Cancer Cell|2020Cited by 142
Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma DevelopmentWarapen Treekitkarnmongkol, Humam Kadara, Maya Hassane et al.|American Journal of Respiratory and Critical Care Medicine|2020Cited by 46
Interleukin-6 Blockade Abrogates Immunotherapy Toxicity and Promotes Tumor ImmunityYared Hailemichael, Adi Diab, Daniel H. Johnson et al.|SSRN Electronic Journal|2021Cited by 24